SCHEMBL190304

SCHEMBL190304

C(=C(c1ccccc1)c1ccc2c(c1C(=Cc1ccccc1)c1ccccc1)=c1ccccc1=2)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.42
CYP19A1 P11511 3/20 0.41
CYP11B2 P19099 2/20 0.41
PTGS2 P35354 4/20 0.36
AKR1C1 Q04828 1/20 0.35
CYP2D6 P10635 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
PRMT1 Q99873 1/20 0.33
AKR1C3 P42330 1/20 0.33
ATM Q13315 1/20 0.32
ESR2 Q92731 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4612461 0.73 ESR1 (0.59) ESR1CYP19A1CYP11B2PTGS2AKR1C1
SCHEMBL4612464 0.73 ESR1 (0.59) ESR1CYP19A1CYP11B2PTGS2AKR1C1
SCHEMBL190303 0.72 ESR1 (0.42) ESR1CYP19A1CYP11B2PTGS2AKR1C1
SCHEMBL190302 0.72 ESR1 (0.42) ESR1CYP19A1CYP11B2PTGS2AKR1C1
SCHEMBL55433 0.71 ESR1 (0.74) ESR1CYP19A1CYP11B2PTGS2AKR1C1
SCHEMBL128790 0.70 ESR1 (0.43) ESR1CYP19A1CYP11B2PTGS2AKR1C1
Bromide SCHEMBL28733230 0.69 ESR1 (0.71) ESR1CYP19A1CYP11B2PTGS2AKR1C1
SCHEMBL30366689 0.69 ESR1 (0.71) ESR1CYP19A1CYP11B2PTGS2AKR1C1
SCHEMBL4612465 0.69 ESR1 (0.78) ESR1CYP19A1CYP11B2PTGS2AKR1C1
Phosphine SCHEMBL28461311 0.69 ESR1 (0.71) ESR1CYP19A1CYP11B2PTGS2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858927-A1 INK COMPOSITION Nissan Chemical Corporation (JP) 2021-08-04 EP disclosed
EP-2537874-B1 SULFONATION OF CONDUCTING POLYMERS AND OLED, PHOTOVOLTAIC, AND ESD DEVICES NISSAN CHEMICAL CORP (JP) 2021-05-19 EP disclosed
US-10870771-B2 Non-aqueous ink compositions containing transition metal complexes, and uses thereof in organic electronics NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2020-12-22 US disclosed
EP-3405534-B1 NON-AQUEOUS INK COMPOSITIONS CONTAINING TRANSITION METAL COMPLEXES, AND USES THEREOF IN ORGANIC ELECTRONICS NISSAN CHEMICAL CORP (JP) 2020-10-14 EP disclosed
US-20200216696-A1 NON-AQUEOUS INK COMPOSITION NISSAN CHEMICAL CORPORATION (JP) 2020-07-09 US disclosed
EP-1816690-B1 OLED with area defined multicolor emission within a single lighting element OSRAM OLED GMBH (DE) 2020-07-01 EP disclosed
EP-3643756-A1 NONAQUEOUS INK COMPOSITION Nissan Chemical Corporation (JP) 2020-04-29 EP disclosed
US-20200032086-A1 COMPOSITIONS CONTAINING HOLE CARRIER MATERIALS AND POLY(ARYL ETHER SULFONE)S, AND USES THEREOF SOLVAY USA INC. 2020-01-30 US disclosed
US-20190330485-A1 INK COMPOSITION NISSAN CHEMICAL CORPORATION (JP) 2019-10-31 US disclosed
US-10435579-B2 Compositions containing hole carrier materials and fluoropolymers, and uses thereof NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2019-10-08 US disclosed
US-6946319-B2 Electrode for an electronic device OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2005-09-20 US disclosed
US-20050062174-A1 Encapsulated organic electronic device OSRAM OPTO SEMICONDUCTORS GMBH 2005-03-24 US disclosed
US-20050057153-A1 Electroluminescent displays and method of fabrication OSRAM OLED GMBH (DE) 2005-03-17 US disclosed
US-20050048314-A1 Hole injection/transport layer is added to device to increase number of holes injected into emissive layer and reduce number of electrons injected OSRAM OPTO SEMICONDUCTORS GMBH (DE) 2005-03-03 US disclosed
US-20040265623-A1 Conducting polymer for electronic devices OSRAM OPTO SEMICONDUCTORS GMBH 2004-12-30 US disclosed
US-20040241972-A1 ELECTRODE FOR AN ELECTRONIC DEVICE OSRAM OPTO SEMICONDUCTORS GMBH 2004-12-02 US disclosed
US-6563262-B1 Thin metal-oxide layer as stable electron-injecting electrode for light emitting diodes DUPONT DISPLAYS, INC. 2003-05-13 US disclosed
WO-2000022683-A9 THIN METAL-OXIDE LAYER AS STABLE ELECTRON-INJECTING ELECTRODE FOR LIGHT EMITTING DIODES UNIAX CORP (US) 2002-08-22 WO disclosed
EP-1133803-A1 THIN METAL-OXIDE LAYER AS STABLE ELECTRON-INJECTING ELECTRODE FOR LIGHT EMITTING DIODES Uniax Corporation (US) 2001-09-19 EP disclosed
WO-2000022683-A1 THIN METAL-OXIDE LAYER AS STABLE ELECTRON-INJECTING ELECTRODE FOR LIGHT EMITTING DIODES UNIAX CORPORATION (US) 2000-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10870771-B2 Non-aqueous ink compositions containing transition metal complexes, and uses thereof in organic electronics TYK2, TNK1, JAK1 ESR1 1567/4885CYP19A1 1859/4885CYP11B2 2140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.